interleukin-2

You have access
Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 – Implications for Clinical Trials
HEIDI TÖRNROOS, HENRY HÄGERSTRAND and CHRISTER LINDQVIST

Anticancer Research January 2019, 39 (1) 107-112; DOI: https://doi.org/10.21873/anticanres.13085
You have access
Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
YUTA TAKEZAWA, KOUJI IZUMI, YUSUKE SHIMURA, MAOLAKE AERKEN, ARIUNBOLD NATSAGDORJI, MASASHI IIJIMA, KAZUYOSHI SHIGEHARA, TAKAHIRO NOHARA, KAZUTAKA NARIMOTO, YOSHIFUMI KADONO, YASUHIDE KITAGAWA, HIROYUKI KONAKA and ATSUSHI MIZOKAMI

Anticancer Research September 2016, 36 (9) 4961-4964;
You have access
Effective Treatment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2
WILLEM DEN OTTER, MARGOT HACK, JOHN J.L. JACOBS, JURGEN F.V. TAN, LAWRENCE ROZENDAAL and R. JEROEN A. VAN MOORSELAAR

Anticancer Research June 2015, 35 (6) 3385-3391;
You have access
Treatment of Transmissible Venereal Tumors in Dogs with Intratumoral Interleukin-2 (IL-2). A Pilot Study
WILLEM DEN OTTER, MARGOT HACK, JOHN J.L. JACOBS, JURGEN F.V. TAN, LAWRENCE ROZENDAAL and R. JEROEN A. VAN MOORSELAAR

Anticancer Research February 2015, 35 (2) 713-717;
You have access
Indoleamine-2,3-dioxygenase in an Immunotherapy Model for Ewing Sarcoma
DANIELA MAX, CASPAR D. KÜHNÖL, STEFAN BURDACH, LIGUO NIU, MARTIN S. STAEGE and JÜRGEN L. FÖLL

Anticancer Research November 2014, 34 (11) 6431-6441;
You have access
Therapeutic Response of Untreatable Hepatocellular Carcinoma After Application of the Immune Modulators IL-2, BCG and Melatonin
BOJIDAR TOMOV, DIMITAR POPOV, RADOSVETA TOMOVA, NICOLA VLADOV, WILLEM DEN OTTER and ZACHARY KRASTEV

Anticancer Research October 2013, 33 (10) 4531-4535;
You have access
Role of Marker Lesion when Applying Intravesical Instillations of IL-2 for Non-muscle-invasive Bladder Cancer Comparison of the Therapeutic Effects in Two Pilot Studies
WILLEM DEN OTTER, R. JEROEN VAN MOORSELAAR, JOHN J.L. JACOBS, RONALD TER HAAR, JAN W. KOTEN, ZYGMUNT DOBROWOLSKI, WACLAW LIPCZYNSKI, VITA PAŠUKONIENĖ, DAINIUS CHARACIEJUS, FELIKSAS JANKEVIČIUS, RIMANTAS EIDUKEVIČIUS and THEO M. DE REIJKE

Anticancer Research May 2013, 33 (5) 2099-2105;
You have access
Intratumoural Interleukin-2 Therapy Can Induce Regression of Non-resectable Mastocytoma in Dogs
PAUL G.P.M. ZIEKMAN, WILLEM DEN OTTER, JURGEN F.V. TAN, ERIK TESKE, JOLLE KIRPENSTEIJN, JAN-WILLEM KOTEN and JOHN J.L. JACOBS

Anticancer Research January 2013, 33 (1) 161-165;

Main menu

User menu

Search

interleukin-2